MedPath

Comparison between plain bupivacaine, bupivacaine with nalbuphine and bupivacaine with buprenorphine in spinal anaesthesia

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/02/040260
Lead Sponsor
DR Prem Sagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS UNDERGOING ELECTIVE LOWERLIMB SURGERIES.

AMERICAN SOCIETY OF ANAESTHESIOLOGIST(ASA) GRADE I & II.

Exclusion Criteria

PREGNANCY.

PATIENTS WITH ALLERGY TO DRUG UNDER STUDY.

PATIENTS WITH SPINAL DEFORMITIES.

SUBJECTS HAVING CONTRAINDICATIONS FOR SPINAL ANAESTHESIA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Study The Onset , Duration Of Sensory And Motor Blockade And Any Adverse Effects Of The Given Drug Intrathecally. <br/ ><br>Timepoint: To Study The Onset , Duration Of Sensory And Motor Blockade And Any Adverse Effects Of The Given Drug Intrathecally. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To Study Any Adverse Effects Of Drugs In Post-Operative PeriodTimepoint: From The Time Of Injection to 24Hours Of Time
© Copyright 2025. All Rights Reserved by MedPath